- Advanced search
- Immuno Portal
- Malaria Portal
Synonyms: Rifadin® | rifampin
rifampicin is an approved drug (FDA (1971))
Compound class: Natural product or derivative
Comment: As with many natural products with complex structures, there is some ambiguity as to the exact structure of rifampicin. Common representations of the structure include CID 5458213, and CID 5381226.
Ligand Activity Visualisation Charts
These are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts.✖
View more information in the IUPHAR Pharmacology Education Project: rifampicin
1. Blumberg B, Sabbagh W, Juguilon H, Bolado J, van Meter CM, Ong ES, Evans RM. (1998)
SXR, a novel steroid and xenobiotic-sensing nuclear receptor.
Genes Dev, 12 (20): 3195-205. [PMID:9784494]
2. Karlgren M, Vildhede A, Norinder U, Wisniewski JR, Kimoto E, Lai Y, Haglund U, Artursson P. (2012)
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
J Med Chem, 55 (10): 4740-63. [PMID:22541068]
3. Lehmann JM, McKee DD, Watson MA, Willson TM, Moore JT, Kliewer SA. (1998)
The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions.
J Clin Invest, 102 (5): 1016-23. [PMID:9727070]
4. Liu X, Huang J, Sun Y, Zhan K, Zhang Z, Hong M. (2013)
Identification of multiple binding sites for substrate transport in bovine organic anion transporting polypeptide 1a2.
Drug Metab Dispos, 41 (3): 602-7. [PMID:23255551]
5. Treiber A, Schneiter R, Häusler S, Stieger B. (2007)
Bosentan is a substrate of human OATP1B1 and OATP1B3: inhibition of hepatic uptake as the common mechanism of its interactions with cyclosporin A, rifampicin, and sildenafil.
Drug Metab Dispos, 35 (8): 1400-7. [PMID:17496208]
6. Vavricka SR, Van Montfoort J, Ha HR, Meier PJ, Fattinger K. (2002)
Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver.
Hepatology, 36 (1): 164-72. [PMID:12085361]